Tertiary structure prediction of SARS coronavirus helicase

被引:24
作者
Bernini, A
Spiga, O
Venditti, V
Prischi, F
Bracci, L
Huang, JD
Tanner, JA
Niccolai, N
机构
[1] Univ Siena, Dept Biol Mol, Biomol Struct Res Ctr, I-53100 Siena, Italy
[2] SienaBiografix Srl, Siena, Italy
[3] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
关键词
SARS coronavirus; protein structure; structure prediction; molecular modeling; helicase structure; drug design;
D O I
10.1016/j.bbrc.2006.03.069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS coronavirus, SCV, has been recently responsible of a sudden and widespread infection which caused almost 800 victims. The limited amount of SCV protein structural information is partially responsible of the lack of specific drugs against the virus. Coronavirus helicases are very conserved and Peculiar proteins which have been proposed as Suitable targets for antiviral drugs, such as bananins, which have been recently shown to inhibit the SCV helicase in vitro. Here, the quaternary structure of SCV helicase has been predicted, which will provide a solid foundation for the rational design of other antiviral helicase inhibitors. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1101 / 1104
页数:4
相关论文
共 29 条
[1]  
Ausiello G, 1997, PROTEINS, V28, P556, DOI 10.1002/(SICI)1097-0134(199708)28:4<556::AID-PROT9>3.3.CO
[2]  
2-C
[3]   Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster [J].
Bellon, SF ;
Rodgers, KK ;
Schatz, DG ;
Coleman, JE ;
Steitz, TA .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (07) :586-591
[4]   Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy [J].
Borowski, P ;
Schalinski, S ;
Schmitz, H .
ANTIVIRAL RESEARCH, 2002, 55 (03) :397-412
[5]   The Amber biomolecular simulation programs [J].
Case, DA ;
Cheatham, TE ;
Darden, T ;
Gohlke, H ;
Luo, R ;
Merz, KM ;
Onufriev, A ;
Simmerling, C ;
Wang, B ;
Woods, RJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1668-1688
[6]   Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease [J].
Crute, JJ ;
Grygon, CA ;
Hargrave, KD ;
Simoneau, B ;
Faucher, AM ;
Bolger, G ;
Kibler, P ;
Liuzzi, M ;
Cordingley, MG .
NATURE MEDICINE, 2002, 8 (04) :386-391
[7]   IDENTIFICATION OF THE PRIMASE ACTIVE-SITE OF THE HERPES-SIMPLEX VIRUS TYPE-1 HELICASE-PRIMASE [J].
DRACHEVA, S ;
KOONIN, EV ;
CRUTE, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :14148-14153
[8]   CORONAVIRUS GENOME - PREDICTION OF PUTATIVE FUNCTIONAL DOMAINS IN THE NON-STRUCTURAL POLYPROTEIN BY COMPARATIVE AMINO-ACID SEQUENCE-ANALYSIS [J].
GORBALENYA, AE ;
KOONIN, EV ;
DONCHENKO, AP ;
BLINOV, VM .
NUCLEIC ACIDS RESEARCH, 1989, 17 (12) :4847-4861
[9]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[10]  
GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866